Custom Lucite, with spinning element, celebrating the successful adoption of ASC 606, new accounting standards regarding the recognition of revenue from contracts with customers.
(8ALJ560)Custom Lucite, with spinning element, celebrating the successful adoption of ASC 606, new accounting standards regarding the recognition of revenue from contracts with customers.
(8ALJ560)Custom Lucite, with an embedded champagne cork, celebrating the approval by the Food and Drug Administration (FDA) of the obesity treatment Plenity. Plenity was developed by Boston-based biotech firm Gelesis.
(9AMF149)Custom crystal tombstone commemorating clinical trial financing provided for biopharmaceutical company, Clovis Oncology. The clinical trial sponsored by Clovis involves an ovarian cancer study.
(9ALJ233)Custom crystal commemorating an exclusive distribution agreement between California-based pharmaceutical firm Zogenix and Japanese pharma company Nippon Shinyaku.
(9ALJ481)Custom crystal celebrating a commercial rights agreement between pharmaceutical firm Zogenix and Nippon Shinyaku. Zogenix focuses on rare disease therapies.
(9ALj481)Pill-themed crystal deal toy commemorating a license agreement between Asahi Kasei Pharma Corporation, headquartered in Tokyo, and New York-based Woolsey Pharmaceuticals.
(9AMF325)Lucite tombstone commemorating a joint venture between pharmaceutical firms Pfizer and GlaxoSmithKline. The joint venture centers on the over-the-counter consumer healthcare business.
(9AKL489)Custom crystal commemorative, incorporating a periodic table theme, marking a licensing and commercialization agreement for a cancer drug developed by Rockville, Maryland-based biotech firm GlycoMimetics. The agreement applies to mainland China, Hong Kong, Taiwan, and Macau.
(20ALJ071)Custom crystal deal toy commemorating the acquisition of Canada’s Dalton Pharma Services by Japanese pharmaceutical firm Seikagaku Corporation.
(20AMF085)